TNFRSF8 and pancreatic adenocarcinoma: They reported positive outcomes in four cases of refractory SS to other lines, one case of SS and adenocarcinoma of the pancreas combined with gemcitabine, one case of advanced MF prior to allotransplantation (Allo-HSCT) treatment, one case of SS in combination with electron body bath and photopheresis, one MF with treatment failure to brentuximab with 10% CD30 expression, and cases of refractory advanced MF.